AGP Executive Report
Last update: 11 hours agoRare Malaria Cluster: Germany is reporting a third death linked to “airport malaria” near Frankfurt Airport, after a mosquito carrying malaria parasites was reportedly transported on a flight; officials say the cases involve Plasmodium falciparum and that the disease isn’t spread person-to-person. Cancer Diagnostics Tech: A new study reports an AI system can score lung cancer treatment response on pathology slides with performance comparable to expert pathologists, aiming to make neoadjuvant chemoimmunotherapy assessment more consistent. Heart Failure Risk Stratification: The CMR GUIDE trial missed its main endpoint for ICDs in certain heart-failure patients, but researchers presented subgroup signals at the ESC Congress that could refine who benefits most. Atrial Fibrillation After Brain Bleed: A clinician briefing reviews the tough trade-off after intracranial hemorrhage—anticoagulation lowers ischemic stroke risk but raises recurrent bleeding—highlighting results from SoSTART and APACHE-AF. Drug Approval (Rare Disease): IntraBio says the FDA approved AQNEURSA (levacetylleucine) for ataxia-telangiectasia, positioning it as the first approved treatment for A-T. Child Health Safety: A German school bus crash sent 16 children to hospital after a tyre burst.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
